Yüklüyor......
Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs
1. Repaglinide, a novel compound with a nonsulphonylurea structure, is currently being clinically tested as a therapeutic agent. In the present study, the hypoglycaemic effects of repaglinide in rats and dogs were investigated. 2. Whereas the R-enantiomer, AG-EE 624 ZW, showed only weak hypoglycaemi...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
1997
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1564864/ https://ncbi.nlm.nih.gov/pubmed/9283692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0701307 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|